Lexicon Pharmaceuticals (LXRX) Tops 4Q Forecasts

Lexicon Pharmaceuticals, Inc. (LXRX) shares are up more than 5% to $1.03 in pre-market trading Wednesday after the company reported its fourth quarter earnings results. The biopharmaceutical firm reported earnings of $0.00 per share on revenues of $21.5 million, up 1435.7% from a year ago. Analysts were expecting EPS of ($0.03) on revenues of $10.31 […] View the full post at: Lexicon Pharmaceuticals (LXRX) Tops 4Q Forecasts Related posts: Fidelity Discloses 14.97% stake in Ariad Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock JPMorgan Posts Better-than-Expected Results